SEC Tracker
Get the app
GEHC · XBRL financial data

GE HealthCare Technologies financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (GEHC's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Revenue from contracts with customers5,206*4,6504,8394,8635,319*4,7775,0075,1435,698*5,1315,2955,513
Gross profit—1,9022,0022,026—2,0121,9851,990—1,9772,1802,224
Research and development315*324327316344*344302292323*345323320
Selling, general and administrative1,152*1,0381,0671,0341,130*1,0401,0291,0451,111*1,1171,1181,100
Total operating expenses1,467*1,3621,3951,3501,474*1,3831,3311,3371,434*1,4621,4411,419
Operating income (loss)689*540608676801*629654653827*515739805
Other income (expense)1*(8)1954*99(1)2633*362219
Income tax expense (benefit)193*12414316896*104113179219*94119129
Net income (loss)403*374428470721*564486446589*389561615
Earnings per share, basic USD per share0.88*0.820.941.031.59*1.231.060.981.30*0.851.241.36
Earnings per share, diluted USD per share0.88*0.810.931.021.57*1.231.060.981.29*0.851.241.36
Weighted average shares, basic millions of shares456*456457457454*457457456454*456453452
Weighted average shares, diluted millions of shares459*459459459459*459458457458*457454453

Balance sheet

CSV

Fiscal quarters (GEHC's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Cash and cash equivalents2,4942,5511,9973,5502,8742,4543,7374,0054,4922,2612,0792,826
Inventory1,9601,9892,0232,1241,9392,1582,2832,3042,2342,3532,4832,628
Total current assets9,4109,3738,80610,6389,9019,73511,30811,89312,50110,42610,49711,495
Property and equipment, net2,144———————————
Right-of-use asset356354359359364369386409410396391383
Goodwill12,93612,92713,11613,13813,13613,37313,41713,44113,48915,06015,09515,140
Total assets32,45432,20831,85233,85533,08933,58635,50036,12736,90637,12537,24638,371
Accounts payable2,9472,9312,8242,9113,0223,1522,9752,9873,2503,4103,2313,320
Current portion of long-term debt1,0021,0031,0031,0041,5002,0002,0022,002502222
Total current liabilities8,9818,8598,3188,6709,5539,9699,74810,0739,1058,5298,3028,815
Long-term debt8,4368,2478,2339,3067,4496,7578,2708,2779,49510,12710,0919,970
Lease liability, non-current273267267263270266271285284270263255
Total liabilities25,14424,60923,85825,34324,43724,16825,54825,90726,30726,22726,02726,508
Retained earnings1,3261,6872,1012,5583,2623,8104,2954,7095,2815,6546,1996,795
Total stockholders' equity7,1337,4087,8018,3178,4469,1879,7129,99310,37910,66810,97511,614
Total liabilities and equity32,45432,20831,85233,85533,08933,58635,50036,12736,90637,12537,24638,371
Common shares outstanding (cover page) millions of shares455456457457457458457456456455452452

Cash flows

CSV

Fiscal quarters (GEHC's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Net income (loss)403*374428470721*564486446589*389561615
Stock-based compensation33*3436*22*33*2234*38*36*3545*36*
Net cash from operating activities—419(119)*——25094*593*—290168*907*
Net cash from investing activities(88)*(188)(349)*(137)*(240)*(407)(223)*(148)*(269)*(2,500)(115)*(111)*
Share repurchasesyear only——0*0*0100*100*0*100200*0*
Dividends paid13*1414*13*14*1616*16*16*1616*16*
Net cash from financing activities(900)*(153)(57)*914*(1,277)*(286)1,361*(165)*(293)*21(236)*(40)*
Net change in cash86*59(547)*1,554*(679)*(416)1,289*264*486*(2,227)(180)*749*

Compare with peers

SIC 3844 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3844 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($M)Revenue, quarter ($M)Operating cash flow, quarter ($M)Shares outstandingQuarter
GE HealthCare Technologies2,8265,513907*452.1M 10-QSep 30, 2026
Dexcom9611,345326*373.0M 10-QSep 30, 2026
Resmed1,0111,415422140.7M 10-QSep 30, 2026
Edwards Lifesciences2,9071,741652*576.4M 10-QJun 30, 2026
STERIS4821,49336797.5M 10-QJun 30, 2026
Insulet53580288*69.4M 10-QJun 30, 2026
Zimmer Biomet Holdings4102,177448*190.7M 10-QJun 30, 2026
Becton Dickinson7084,983not reported272.4M 10-QJun 30, 2026
Baxter International1,9752,976558*517.3M 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.